InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Paul L Berns, a See Remarks, is a corporate insider tracked by InsiderTape across 5 companies. The public record shows 6 open-market SEC Form 4 transactions: 3 purchases worth $46.7M and 3 sales worth $281K, reported from Aug 5, 21 to Jun 22, 26. Over this period they have been a mix of buying and selling.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 22, 26 | KARDKardigan, Inc. | BUY | 1.25M | $16.00 | $20.0M |
| Mar 6, 26 | LYELLyell Immunopharma, Inc. | BUY | 488.1K | $25.61 | $12.5M |
| Feb 17, 26 | NMRANeumora Therapeutics, Inc. | SELL | 9.8K | $3.51 | $34K |
| Feb 18, 25 | NMRANeumora Therapeutics, Inc. | SELL | 13.9K | $1.69 | $23K |
| Feb 3, 25 | MTSRMetsera, Inc. | BUY | 790.0K | $18.00 | $14.2M |
| Aug 5, 21 | JAZZJazz Pharmaceuticals plc | SELL | 1.4K | $154.00 | $223K |